Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)

Resection of colorectal liver metastases (CRLM) is a potential curative treatment for patients with metastatic colorectal cancer (mCRC) with liver-limited disease (LLD). Although long-term survival improved considerably within the last decades, high recurrence rates of 50-75% after resection remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Schimanski, Carl Christoph, Kasper, Stefan, Hegewisch-Becker, Susanna, Schröder, Jan, Overkamp, Friedrich, Kullmann, Frank, Bechstein, Wolf Otto, Vöhringer, Matthias, Öllinger, Robert, Lordick, Florian, Heinemann, Volker, Geißler, Michael, Schulz-Abelius, Armin, Bernhard, Helga, Schön, Michael R., Greil, Richard, Galle, Peter, Lang, Hauke, Schmidtmann, Irene, Moehler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458621/
https://www.ncbi.nlm.nih.gov/pubmed/32923171
http://dx.doi.org/10.1080/2162402X.2020.1806680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458621/
https://www.ncbi.nlm.nih.gov/pubmed/32923171
http://dx.doi.org/10.1080/2162402X.2020.1806680

Ejemplares similares